e-learning
resources
Milan 2017
Sunday, 10.09.2017
The spectrum of CTDs: from pathogenesis to treatment
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Comorbid interstitial lung diseases and collagen vascular diseases in pulmonary alveolar proteinosis: a nationwide surveillance in Japan
Y. Inoue (Osaka, Japan)
Source:
International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment
Session:
The spectrum of CTDs: from pathogenesis to treatment
Session type:
Thematic Poster
Number:
882
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Y. Inoue (Osaka, Japan). Comorbid interstitial lung diseases and collagen vascular diseases in pulmonary alveolar proteinosis: a nationwide surveillance in Japan. 882
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Pulmonary hypertension in interstitial lung diseases
Source: Annual Congress 2009 - Sarcoidosis and profiles of other diffuse parenchymal lung disease
Year: 2009
Surveillance of whole lung lavage for autoimmune pulmonary alveolar proteinosis in Japan
Source: Annual Congress 2013 –Diffuse parenchymal lung disease I
Year: 2013
Autoimmune pulmonary alveolar proteinosis complicated with infections: a nationwide surveillance study in Japan
Source: International Congress 2017 – Rare diseases
Year: 2017
Comparison of registries of interstitial lung diseases in three European countries
Source: Eur Respir J 2001; 18: 114S-118S
Year: 2001
Pulmonary hypertension in different interstitial lung diseases
Source: Annual Congress 2012 - Diffuse parenchymal lung disease: clinical profiles and collagen vascular disease
Year: 2012
Fatal cases of pulmonary alveolar proteinosis: a nationwide surveillance in Japan
Source: International Congress 2018 – Progress in rare interstitial lung diseases
Year: 2018
Intercurrent intractable factors in autoimmune pulmonary alveolar proteinosis
Source: Annual Congress 2009 - Various backgrounds in diffuse parenchymal lung disease
Year: 2009
The epidemiology of idiopathic pulmonary fibrosis and interstitial lung diseases at risk of a progressive-fibrosing phenotype
Source: Eur Respir Rev, 27 (150) 180077; 10.1183/16000617.0077-2018
Year: 2018
Pivotal clinical dilemmas in collagen vascular diseases associated with interstitial lung involvement
Source: Eur Respir J 2009; 33: 882-896
Year: 2009
Prevalence and incidence of interstitial lung diseases (ILDs) in a French multi-ethnic county
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view
Year: 2013
Genetics of fibrosing lung diseases
Source: Eur Respir J 2005; 25: 915-927
Year: 2005
Pulmonary hypertension in interstitial lung disease
Source: Eur Respir J 2008; 31: 1357-1367
Year: 2008
Rare interstitial lung diseases of environmental origin
Source: Eur Respir Mon 2011; 54: 301-316
Year: 2011
Women: lung and autoimmune disease
Source: ISSN=1025-448x, ISBN=1-904097-28-6, page=190
Year: 2003
Pulmonary rehabilitation in interstitial lung diseases compared with chronic obstructive pulmonary disease
Source: International Congress 2019 – Pulmonary rehabilitation for non-obstructive lung diseases
Year: 2019
Distribution of pleural plaques and pulmonary fibrosis due to asbestos exposure: Radiological patterns in asbestos-related disorders (ARDs)
Source: International Congress 2015 – Interstitial lung diseases I
Year: 2015
Treatment of progressive fibrosing interstitial lung diseases: a milestone in the management of interstitial lung diseases
Source: Eur Respir Rev, 28 (153) 190109; 10.1183/16000617.0109-2019
Year: 2019
Rheumatoid arthritis and comorbid chronic obstructive or interstitial pulmonary diseases: Prevalence in a population-based cohort
Source: International Congress 2016 – Burden of respiratory diseases: from environmental aspects to healthcare consumption
Year: 2016
Clubbing in patients with fibrotic interstitial lung diseases
Source: International Congress 2017 – ILDs: clinical problems
Year: 2017
Spectrum of interstitial lung diseases (ILDs) and associated prevalence of pulmonary hypertension
Source: Virtual Congress 2021 – Pulmonary hypertension in the COVID-19 pandemic and beyond
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept